How to buy KLA (KLAC) stock from India

Yes, an Indian resident can buy KLA Corporation — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% that decides your outcome is tax, estate-tax exposure, and position sizing. KLAC pays a small dividend, so you do touch US withholding and Form 67 paperwork, but the position is dominated by capital gains. This is the short version.

The 30-second version

• Legal and simple. Buy KLAC via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole shares or a fractional rupee amount.
• Mostly capital-gains, small dividend tail. KLAC pays a modest dividend (roughly 0.8 to 1% yield). The US withholds 25% under the India-US DTAA; you claim a foreign tax credit in India via Form 67 (replaced by Form 44 from TY2026-27).
• India tax: hold more than 24 months and pay 12.5% LTCG (no indexation); sell sooner and pay your slab rate. This is Section 112, not the friendlier 112A that Indian shares get.
• The trap most miss: directly-held KLAC is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
• If your thesis is "US semis," SOXX or SMH already hold KLAC as a top weight — same exposure, no single-stock risk.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	KLAC / Nasdaq
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	A fraction of one share (fractional lets you invest an exact rupee amount)
Dividend	Yes — small, ~0.8-1% yield, quarterly; 25% US withholding under DTAA
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold; Form 67/44 for dividend FTC

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) for a simple India-funded experience, or a global broker (Interactive Brokers, Rovia) for wider access. File your W-8BEN during onboarding — this is what gets you the 25% DTAA rate on the dividend instead of the punitive 30% non-treaty rate. New to this? Start with how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. KLAC trades in the high-hundreds of dollars per share, so a whole share is meaningful capital — fractional rupee orders let you size sensibly without buying a full share at a time.

The tax that actually matters

KLAC pays a small but real dividend, so you have two India-tax surfaces: dividends and capital gains. The dividend is the recurring admin; the gain is where most of the money is.

Dividend. The US withholds 25% under the India-US DTAA (the W-8BEN gets you that rate; non-filers see 30%). India then taxes the gross dividend at your slab rate, and you claim the 25% US tax as a foreign tax credit via Form 67 — replaced by Form 44 from assessment year 2026-27 onwards. Form 44 must be filed before your ITR for the credit to be allowed. Detail: dividend withholding and Form 67.

Capital gains. Under Section 112 (foreign shares don't get the Section 112A treatment Indian-listed equity enjoys):

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 4 shares at $750 when USD/INR is 86 → cost 2,58,000 rupees. Sell 28 months later at $880 when USD/INR is 88 → proceeds 3,09,760 rupees. Taxable gain 51,760 rupees; LTCG at 12.5% = 6,470 rupees. The gain is computed in rupees, so a weaker rupee at sale amplifies your reported gain even when the dollar move is modest. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India.

The $60,000 estate-tax trap

Directly-held KLAC is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there is no credit or relief. With KLAC trading in the high-hundreds, a $60k threshold is roughly 70 to 90 shares — easy to cross unintentionally. The fix (holding through pooled or fund structures rather than direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get KLA through an ETF?

If you want…	Best route
A concentrated bet that KLAC's process-control monopoly compounds	KLAC directly
"US semi-cap-eq cycle" exposure	SOXX or SMH — KLAC is a major weight alongside ASML, AMAT, LRCX
Broad US tech exposure with KLAC inside	QQQ, VTI, VOO — KLAC is a Nasdaq 100 and S&P 500 constituent
The least single-stock risk	A broad index ETF

KLAC is a top holding in the semiconductor-themed ETFs SOXX (iShares) and SMH (VanEck) — those give you concentrated semi-cycle exposure with the rest of the leading-edge stack (NVDA, AVGO, ASML, AMAT, LRCX). It is also a Nasdaq 100 and S&P 500 member, so QQQ, VTI and VOO hold KLAC at a smaller weight. Compare routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader case is in US ETFs for Indians.

The business in one screen

What it is: KLA is the global monopolist of semiconductor process control — the inspection and metrology tools that find defects on wafers and reticles during fab production. Roughly 70% share in advanced inspection, with the position widening as leading-edge nodes (3nm, 2nm, gate-all-around, high-NA EUV) push defect densities lower and make every missed defect more expensive. Process-control intensity (inspection capex as a percentage of total wafer-fab equipment spend) grows faster than overall WFE because the physics demand it. The customer list is the entire leading-edge logic and memory world — TSMC, Samsung, Intel, SK Hynix, Micron — with TSMC the largest single name.

Bull case	Bear case
~70% share in advanced process control — closest thing in semi-cap-eq to a monopoly	Equipment spending is structurally cyclical — WFE down-cycles hit revenue hard
Leading-edge node complexity makes inspection intensity rise faster than overall WFE	China revenue exposure under widening US export controls
High-margin services and parts annuity from an installed base of irreplaceable tools	Customer concentration — TSMC is a dominant single buyer
Direct beneficiary of high-NA EUV, gate-all-around and advanced-packaging ramps	Advanced-packaging inspection is a newer fight where share is not yet locked in
Cash generative through cycles, returns it via buybacks and a steady dividend	Premium valuation already prices in much of the structural story

Exact valuation is in the live widget above — a structurally advantaged compounder, priced as one.

Our take

Verdict: BUY — process-control is the most defensible position in semi-cap-eq, and leading-edge complexity is doing the heavy lifting on demand.

• The closest thing to a monopoly in semi-cap-eq. ASML owns lithography; KLA owns process control. Roughly 70% share in advanced wafer and reticle inspection and metrology, with switching costs measured in qualified recipes and years of tool data. Customers cannot dual-source the way they can with deposition or etch.
• Inspection capex grows faster than WFE. Each node shrink (3nm to 2nm, high-NA EUV, gate-all-around transistors) makes defects smaller, denser, and more expensive to miss — so process-control intensity rises structurally. KLAC's revenue compounds faster than the overall equipment market through a full cycle.
• A real dividend and a real cash machine. Around a 0.8 to 1% yield, growing, plus aggressive buybacks. The yield is small enough that the Form 67 (and Form 44 from TY2026-27) friction is manageable; the gain is where the thesis lives. Fits as a high-conviction satellite for an Indian investor wanting leveraged exposure to the leading-edge node roadmap.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Cycle correlation with leading-edge node timing. KLAC's share price is unusually tightly tied to when TSMC, Samsung and Intel actually ramp the next node. A six-to-nine month slip in 2nm or gate-all-around shows up immediately in orders and the multiple.
• China export controls widening. A meaningful slice of revenue comes from Chinese fabs. Further US restrictions on tool sales to China — or Chinese retaliation — would compress the addressable market quickly, with no easy substitute customer.
• Memory-cycle whiplash. Memory capex (DRAM, NAND) swings violently. A down-cycle there can knock a full year of growth off the trajectory even when logic is fine.
• Advanced-packaging share threats. Inspection and metrology for advanced packaging (CoWoS, hybrid bonding) is a newer arena where AMAT and others compete harder; KLAC's leadership here is not yet as entrenched as in front-end wafer inspection.
• Customer concentration. TSMC is a dominant single customer. Any pause, capex cut or sourcing shift there hits KLAC disproportionately.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose KLAC in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper.
• Position size: a single semi-cap-eq name, however monopolistic, is still riding the same wafer-fab equipment cycle as the rest of the stack. Size KLAC as a high-conviction satellite, not a substitute for a broad ETF.

Bottom line

Buying KLAC from India is easy and legal. What needs thought isn't the buying — it's that KLAC is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a $60k estate-tax trap, a small-dividend payer that drags in 25% US withholding and Form 67 (Form 44 from TY2026-27), and a cyclical leading-edge name that swings with node-introduction timing and China policy. The upside: it owns the most defensible niche in the entire semi-cap-eq stack. If your real thesis is "the leading-edge node ramp," SOXX or SMH gives the same trade without the concentration. For accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.